HKU Scholars Hub: Search

Search

Results 1-25 of 89 (Search time: 0.027 seconds).

previous
1
2
3
4
next

	Title	Author(s)	Issue Date	Views
	Constitutive overexpression of cyclin D1 but not cyclin E confers acute resistance to antiestrogens in T-47D breast cancer cells Journal:Cancer Research	Hui, Rina Finney, Georgina L.Carroll, Jason S.Lee, Christine S.L.Musgrove, Elizabeth A.Sutherland, Robert L.	2002
	Cyclin D1 and estrogen receptor messenger RNA levels are positively correlated in primary breast cancer Journal:Clinical Cancer Research	Hui, Rina Cornish, Ann L.McClelland, Richard A.Robertson, John F.R.Blamey, Roger W.Musgrove, Elizabeth A.Nicholson, Robert I.Sutherland, Robert L.	1996
	Overexpression of cyclin D1 messenger RNA predicts for poor prognosis in estrogen receptor-positive breast cancer Journal:Clinical Cancer Research	Kenny, Frances S.Hui, Rina Musgrove, Elizabeth A.Gee, Julia M.W.Blamey, Roger W.Nicholson, Robert I.Sutherland, Robert L.Robertson, John F.R.	1999
	INK4a gene expression and methylation in primary breast cancer: Overexpression of p16(INK4a) messenger RNA is a marker of poor prognosis Journal:Clinical Cancer Research	Hui, Rina Macmillan, R. Douglas Kenny, Frances S.Musgrove, Elizabeth A.Blamey, Roger W.Nicholson, Robert I.Robertson, John F.R.Sutherland, Robert L.	2000
	Radiotherapy and concurrent chemotherapy for oesophageal carcinoma Journal:Australasian Radiology	HUI, RINA BULL, COLIN A.GEBSKI, VAL O'ROURKE, IAN	1994
	Cyclin D1 amplification is not associated with reduced overall survival in primary breast cancer but may predict early relapse in patients with features of good prognosis Journal:Clinical Cancer Research	Seshadri, Ram Lee, Christine S.L.Hui, Rina McCaul, Kieran Horsfall, David J.Sutherland, Robert L.	1996
	Response Rate and Survival at Key Timepoints With PD-1 Blockade vs Chemotherapy in PD-L1 Subgroups: Meta-Analysis of Metastatic NSCLC Trials Journal:JNCI Cancer Spectrum	Man, Johnathan Millican, Jared Mulvey, Arthur Gebski, Val Hui, Rina	2021
	Patient-reported outcomes following pembrolizumab or placebo plus pemetrexed and platinum in patients with previously untreated, metastatic, non-squamous non-small-cell lung cancer (KEYNOTE-189): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial Journal:The Lancet Oncology	Garassino, Marina C.Gadgeel, Shirish Esteban, Emilio Felip, Enriqueta Speranza, Giovanna Domine, Manuel Hochmair, Maximilian J.Powell, Steven Cheng, Susanna Yee Shan Bischoff, Helge G.Peled, Nir Reck, Martin Hui, Rina Garon, Edward B.Boyer, Michael Wei, Ziwen Burke, Thomas Pietanza, M. Catherine Rodríguez-Abreu, Delvys	2020
	Durvalumab after chemoradiotherapy in stage III non–small-cell lung cancer Journal:New England Journal of Medicine	Antonia, S. J.Villegas, A.Daniel, D.Vicente, D.Murakami, S.Hui, R.Yokoi, T.Chiappori, A.Lee, K. H.De Wit, M.Cho, B. C.Bourhaba, M.Quantin, X.Tokito, T.Mekhail, T.Planchard, D.Kim, Y. C.Karapetis, C. S.Hiret, S.Ostoros, G.Kubota, K.Gray, J. E.Paz-Ares, L.De Castro Carpeño, J.Wadsworth, C.Melillo, G.Jiang, H.Huang, Y.Dennis, P. A.Özgüroğlu, M.	2017
	Pembrolizumab plus chemotherapy in metastatic non-small-cell lung cancer Journal:New England Journal of Medicine	Gandhi, L.Rodríguez-Abreu, D.Gadgeel, S.Esteban, E.Felip, E.De Angelis, F.Domine, M.Clingan, P.Hochmair, M. J.Powell, S. F.Cheng, S. Y.S.Bischoff, H. G.Peled, N.Grossi, F.Jennens, R. R.Reck, M.Hui, R.Garon, E. B.Boyer, M.Rubio-Viqueira, B.Novello, S.Kurata, T.Gray, J. E.Vida, J.Wei, Z.Yang, J.Raftopoulos, H.Pietanza, M. C.Garassino, M. C.	2018
	Left ventricular systolic function in HER2/neu negative breast cancer patients treated with anthracycline chemotherapy: A comparative analysis of left ventricular ejection fraction and myocardial strain imaging over 12 months Journal:European Journal of Cancer	Stoodley, Paul W.Richards, David A.B.Boyd, Anita Hui, Rina Harnett, Paul R.Meikle, Steven R.Byth, Karen Stuart, Kirsty Clarke, Jillian L.Thomas, Liza	2013
	PD-1 inhibitors induced bullous lichen planus-like reactions: A rare presentation and report of three cases Journal:Melanoma Research	Wakade, Deepal V.Carlos, Giuliana Hwang, Shelley J.E.Chou, Shaun Hui, Rina Fernandez-Peñas, Pablo	2016
	Pembrolizumab as first-line therapy for patients with PD-L1-positive advanced non-small cell lung cancer: A phase 1 trial Journal:Annals of Oncology	Hui, R.Garon, E. B.Goldman, J. W.Leighl, N. B.Hellmann, M. D.Patnaik, A.Gandhi, L.Eder, J. P.Ahn, M. J.Horn, L.Felip, E.Carcereny, E.Rangwala, R.Lubiniecki, G. M.Zhang, J.Emancipator, K.Roach, C.Rizvi, N. A.	2017
	Anthracyclines induce early changes in left ventricular systolic and diastolic function: A single centre study Journal:PLoS ONE	Boyd, Anita Stoodley, Paul Richards, David Hui, Rina Harnett, Paul Vo, Kim Marwick, Tom Thomas, Liza	2017
	Impact of physical activity on fatigue and quality of life in people with advanced lung cancer: A randomized controlled trial Journal:Annals of Oncology	Dhillon, H. M.Bell, M. L.van der Ploeg, H. P.Turner, J. D.Kabourakis, M.Spencer, L.Lewis, C.Hui, R.Blinman, P.Clarke, S. J.Boyer, M. J.Vardy, Janette L.	2017
	Health-related quality-of-life results for pembrolizumab versus chemotherapy in advanced, PD-L1-positive NSCLC (KEYNOTE-024): a multicentre, international, randomised, open-label phase 3 trial Journal:The Lancet Oncology	Brahmer, Julie R.Rodríguez-Abreu, Delvys Robinson, Andrew G.Hui, Rina Csőszi, Tibor Fülöp, Andrea Gottfried, Maya Peled, Nir Tafreshi, Ali Cuffe, Sinead O'Brien, Mary Rao, Suman Hotta, Katsuyuki Zhang, Jin Lubiniecki, Gregory M.Deitz, Anne C.Rangwala, Reshma Reck, Martin	2017
	Outcomes with durvalumab by tumour PD-L1 expression in unresectable, stage III non-small-cell lung cancer in the PACIFIC trial Journal:Annals of Oncology	Paz-Ares, L.Spira, A.Raben, D.Planchard, D.Cho, B. C.Özgüroğlu, M.Daniel, D.Villegas, A.Vicente, D.Hui, R.Murakami, S.Spigel, D.Senan, S.Langer, C. J.Perez, B. A.Boothman, A. M.Broadhurst, H.Wadsworth, C.Dennis, P. A.Antonia, S. J.Faivre-Finn, C.	2020
	Final Efficacy Results of Neratinib in HER2-positive Hormone Receptor-positive Early-stage Breast Cancer From the Phase III ExteNET Trial Journal:Clinical Breast Cancer	Chan, Arlene Moy, Beverly Mansi, Janine Ejlertsen, Bent Holmes, Frankie Ann Chia, Stephen Iwata, Hiroji Gnant, Michael Loibl, Sibylle Barrios, Carlos H.Somali, Isil Smichkoska, Snezhana Martinez, Noelia Alonso, Mirta Garcia Link, John S.Mayer, Ingrid A.Cold, Søren Murillo, Serafin Morales Senecal, Francis Inoue, Kenichi Ruiz-Borrego, Manuel Hui, Rina Denduluri, Neelima Patt, Debra Rugo, Hope S.Johnston, Stephen R.D.Bryce, Richard Zhang, Bo Xu, Feng Wong, Alvin Martin, Miguel	2021
	Occult metastatic thyroid cancer diagnosed during breast cancer axillary sentinel node biopsy Journal:Endocrinology, Diabetes and Metabolism Case Reports	Herle, Pratima Boyages, Steven Hui, Rina Nahar, Najmun Ngui, Nicholas K.	2020
	CDK4/6 inhibitor plus endocrine therapy for hormone receptor-positive, HER2-negative metastatic breast cancer: The new standard of care Journal:Asia-Pacific Journal of Clinical Oncology	Hui, Rina de Boer, Richard Lim, Elgene Yeo, Belinda Lynch, Jodi	2021
	Updated analysis from KEYNOTE-189: Pembrolizumab or placebo plus pemetrexed and platinum for previously untreated metastatic nonsquamous non–small-cell lung cancer Journal:Journal of Clinical Oncology	Gadgeel, Shirish Rodríguez-Abreu, Delvys Speranza, Giovanna Esteban, Emilio Felip, Enriqueta Dómine, Manuel Hui, Rina Hochmair, Maximilian J.Clingan, Philip Powell, Steven F.Yee-Shan Cheng, Susanna Bischoff, Helge G.Peled, Nir Grossi, Francesco Jennens, Ross R.Reck, Martin Garon, Edward B.Novello, Silvia Rubio-Viqueira, Belén Boyer, Michael Kurata, Takayasu Gray, Jhanelle E.Yang, Jing Bas, Tuba Pietanza, M. Catherine Garassino, Marina C.	2020
	Simplified phenotyping of CYP2D6 for tamoxifen treatment using the N-desmethyl-tamoxifen/ endoxifen ratio Journal:Breast	Lee, Clara Inkyung Low, Siew Kee Maldonado, Ricardo Fox, Peter Balakrishnar, Bavanthi Coulter, Sally de Bruijn, Peter Koolen, Stijn L.W.Gao, Bo Lynch, Jodi Zdenkowski, Nicholas Hui, Rina Liddle, Christopher Mathijssen, Ron H.J.Wilcken, Nicholas Wong, Mark Gurney, Howard	2020
	Optimizing care for younger women with hormone receptor-positive, HER2-negative metastatic breast cancer Journal:Asia-Pacific Journal of Clinical Oncology	de Boer, Richard Hui, Rina Lim, Elgene Yeo, Belinda Zdenkowski, Nicholas	2020
	Emerging data and future directions for CDK4/6 inhibitor treatment of patients with hormone receptor positive HER2-non-amplified metastatic breast cancer Journal:Asia-Pacific Journal of Clinical Oncology	Lim, Elgene Beith, Jane Boyle, Frances de Boer, Richard Hui, Rina McCarthy, Nicole Redfern, Andrew Wade, Theresa Woodward, Natasha	2018
	Hormone receptor positive, HER2 negative metastatic breast cancer: Impact of CDK4/6 inhibitors on the current treatment paradigm Journal:Asia-Pacific Journal of Clinical Oncology	Boyle, Frances Beith, Jane Burslem, Katie de Boer, Richard Hui, Rina Lim, Elgene McCarthy, Nicole Redfern, Andrew Woodward, Natasha	2018